These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 18772339)
1. Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome. Siu MK; Wong ES; Chan HY; Ngan HY; Chan KY; Cheung AN Am J Pathol; 2008 Oct; 173(4):1165-72. PubMed ID: 18772339 [TBL] [Abstract][Full Text] [Related]
2. Downregulation of ASPP1 in gestational trophoblastic disease: correlation with hypermethylation, apoptotic activity and clinical outcome. Mak VC; Lee L; Siu MK; Wong OG; Lu X; Ngan HY; Wong ES; Cheung AN Mod Pathol; 2011 Apr; 24(4):522-32. PubMed ID: 21102414 [TBL] [Abstract][Full Text] [Related]
3. FBI-1 Is Overexpressed in Gestational Trophoblastic Disease and Promotes Tumor Growth and Cell Aggressiveness of Choriocarcinoma via PI3K/Akt Signaling. Mak VC; Wong OG; Siu MK; Wong ES; Ng WY; Wong RW; Chan KK; Ngan HY; Cheung AN Am J Pathol; 2015 Jul; 185(7):2038-48. PubMed ID: 26093985 [TBL] [Abstract][Full Text] [Related]
4. p21-Activated kinase-1 promotes aggressive phenotype, cell proliferation, and invasion in gestational trophoblastic disease. Siu MK; Yeung MC; Zhang H; Kong DS; Ho JW; Ngan HY; Chan DC; Cheung AN Am J Pathol; 2010 Jun; 176(6):3015-22. PubMed ID: 20413688 [TBL] [Abstract][Full Text] [Related]
5. miR-21 Is Overexpressed in Hydatidiform Mole Tissues and Promotes Proliferation, Migration, and Invasion in Choriocarcinoma Cells. Wang YX; Zhao JR; Xu YY; Wu WB; Zhang HJ Int J Gynecol Cancer; 2017 Feb; 27(2):364-374. PubMed ID: 27922982 [TBL] [Abstract][Full Text] [Related]
6. Methylation status and expression of E-cadherin and cadherin-11 in gestational trophoblastic diseases. Xue WC; Feng HC; Tsao SW; Chan KY; Ngan HY; Chiu PM; Maccalman CD; Cheung AN Int J Gynecol Cancer; 2003; 13(6):879-88. PubMed ID: 14675328 [TBL] [Abstract][Full Text] [Related]
7. Downregulation of PDCD4 by deSUMOylation associates with the progression of gestational trophoblastic disease. Wang YX; Cui L; Wu WB; Quinn MJ; Menon R; Zhao JR; Zhang HJ Placenta; 2022 Dec; 130():17-24. PubMed ID: 36370491 [TBL] [Abstract][Full Text] [Related]
8. Apoptotic activity in gestational trophoblastic disease correlates with clinical outcome: assessment by the caspase-related M30 CytoDeath antibody. Chiu PM; Ngan YS; Khoo US; Cheung AN Histopathology; 2001 Mar; 38(3):243-9. PubMed ID: 11260306 [TBL] [Abstract][Full Text] [Related]
9. Apoptosis in gestational trophoblastic disease is correlated with clinical outcome and Bcl-2 expression but not Bax expression. Wong SY; Ngan HY; Chan CC; Cheung AN Mod Pathol; 1999 Nov; 12(11):1025-33. PubMed ID: 10574599 [TBL] [Abstract][Full Text] [Related]
10. The tumor suppressor gastrokine-1 is expressed in placenta and contributes to the regulation of trophoblast migration. Fahlbusch FB; Ruebner M; Huebner H; Volkert G; Zuern C; Thiel F; Koch M; Menendez-Castro C; Wachter DL; Hartner A; Rascher W Placenta; 2013 Nov; 34(11):1027-35. PubMed ID: 23993393 [TBL] [Abstract][Full Text] [Related]
11. Overexpressed PAK4 promotes proliferation, migration and invasion of choriocarcinoma. Zhang HJ; Siu MK; Yeung MC; Jiang LL; Mak VC; Ngan HY; Wong OG; Zhang HQ; Cheung AN Carcinogenesis; 2011 May; 32(5):765-71. PubMed ID: 21325635 [TBL] [Abstract][Full Text] [Related]
12. Distinct microRNA profiles for complete hydatidiform moles at risk of malignant progression. Lin LH; Maestá I; St Laurent JD; Hasselblatt KT; Horowitz NS; Goldstein DP; Quade BJ; Sun SY; Braga A; Fisher RA; Berkowitz RS; Elias KM Am J Obstet Gynecol; 2021 Apr; 224(4):372.e1-372.e30. PubMed ID: 33031755 [TBL] [Abstract][Full Text] [Related]
13. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor. Tuncer ZS; Vegh GL; Fulop V; Genest DR; Mok SC; Berkowitz RS Gynecol Oncol; 2000 Jun; 77(3):389-93. PubMed ID: 10831347 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of the Parkinson disease protein DJ-1 and its regulator PTEN in gestational trophoblastic disease. Zhang HJ; Siu MK; Jiang LL; Mak VC; Ngan HY; Cheung AN Int J Gynecol Pathol; 2010 Sep; 29(5):468-75. PubMed ID: 20736773 [TBL] [Abstract][Full Text] [Related]
15. Identification of microRNA signature in the progression of gestational trophoblastic disease. Zhao JR; Cheng WW; Wang YX; Cai M; Wu WB; Zhang HJ Cell Death Dis; 2018 Jan; 9(2):94. PubMed ID: 29367697 [TBL] [Abstract][Full Text] [Related]
17. Knockdown of lncRNA OGFRP1 Inhibits Proliferation and Invasion of JEG-3 Cells Via AKT/mTOR Pathway. Meng Q; Xue H Technol Cancer Res Treat; 2020; 19():1533033820905823. PubMed ID: 32233835 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of ASPP2 in choriocarcinoma contributes to increased migratory potential through Src signaling pathway activation. Mak VC; Lee L; Siu MK; Wong OG; Lu X; Ngan HY; Wong ES; Cheung AN Carcinogenesis; 2013 Sep; 34(9):2170-7. PubMed ID: 23671128 [TBL] [Abstract][Full Text] [Related]
19. Reduced expression of tissue inhibitor of metalloproteinase (TIMP)-2 in gestational trophoblastic diseases. Okamoto T; Niu R; Yamada S; Osawa M Mol Hum Reprod; 2002 Apr; 8(4):392-8. PubMed ID: 11912288 [TBL] [Abstract][Full Text] [Related]
20. Activated Stat3 expression in gestational trophoblastic disease: correlation with clinicopathological parameters and apoptotic indices. Chan HY; Siu MK; Zhang HJ; Wong ES; Ngan HY; Chan KY; Cheung AN Histopathology; 2008 Aug; 53(2):139-46. PubMed ID: 18752497 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]